{"nct_id":"NCT04396340","title":"First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b","status":"TERMINATED","status_verified_date":"2024-03","start_date":"2020-05-11","start_date_type":"ACTUAL","primary_completion_date":"2022-09-30","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRSN"]}